These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9786873)

  • 1. New synthetic non-peptide ligands for classical major histocompatibility complex class I molecules.
    Bianco A; Brock C; Zabel C; Walk T; Walden P; Jung G
    J Biol Chem; 1998 Oct; 273(44):28759-65. PubMed ID: 9786873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
    Fremont DH; Stura EA; Matsumura M; Peterson PA; Wilson IA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2479-83. PubMed ID: 7708669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimetics of a T cell epitope based on poly-N-acylated amine backbone structures induce T cells in vitro and in vivo.
    Hin S; Bianco A; Zabel C; Jung G; Walden P
    J Biol Chem; 2001 Dec; 276(52):48790-6. PubMed ID: 11600499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide binding to MHC class I is determined by individual pockets in the binding groove.
    Johansen TE; McCullough K; Catipovic B; Su XM; Amzel M; Schneck JP
    Scand J Immunol; 1997 Aug; 46(2):137-46. PubMed ID: 9583994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.
    Zhang W; Young AC; Imarai M; Nathenson SG; Sacchettini JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8403-7. PubMed ID: 1325657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries.
    Udaka K; Wiesmüller KH; Kienle S; Jung G; Walden P
    J Exp Med; 1995 Jun; 181(6):2097-108. PubMed ID: 7539039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.
    Abualrous ET; Saini SK; Ramnarayan VR; Ilca FT; Zacharias M; Springer S
    PLoS One; 2015; 10(8):e0135421. PubMed ID: 26270965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Hydroxy-amide analogues of MHC-class I peptide ligands with nanomolar binding affinities.
    Bianco A; Zabel C; Walden P; Jung G
    J Pept Sci; 1998 Dec; 4(8):471-8. PubMed ID: 9927253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides.
    Hudrisier D; Mazarguil H; Oldstone MB; Gairin JE
    Mol Immunol; 1995 Aug; 32(12):895-907. PubMed ID: 7565816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding.
    Saito Y; Peterson PA; Matsumura M
    J Biol Chem; 1993 Oct; 268(28):21309-17. PubMed ID: 8407969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Fremont DH; Matsumura M; Stura EA; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):919-27. PubMed ID: 1323877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
    Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
    Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide selection by an MHC H-2Kb class I molecule devoid of the central anchor ("C") pocket.
    Molano A; Erdjument-Bromage H; Fremont DH; Messaoudi I; Tempst P; Nikolić-Zugić J
    J Immunol; 1998 Mar; 160(6):2815-23. PubMed ID: 9510184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
    J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure in expression of structurally altered (CYS164-->TYR) H-2Kb molecules is mitigated with high affinity peptide-ligand.
    Tatake RJ; Zeff RA
    Transplantation; 1995 May; 59(9):1343-9. PubMed ID: 7762072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of anchor residue modifications on the stability of major histocompatibility complex class I-peptide interactions.
    Neefjes JJ; Dierx J; Ploegh HL
    Eur J Immunol; 1993 Apr; 23(4):840-5. PubMed ID: 8384560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.
    Lazoura E; Lodding J; Farrugia W; Ramsland PA; Stevens J; Wilson IA; Pietersz GA; Apostolopoulos V
    Immunology; 2006 Nov; 119(3):306-16. PubMed ID: 17067310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.